Although this study investigates PA imaging of PAtrace for FRα+ SKOV3 ovarian cancer, this technology can be applied to a variety of cell receptors (e.g., epidermal growth factor receptor) and cancer cells that are accessible with PA imaging. This evidence concerns the gene FOLR1 and ovarian carcinoma.